Clinical Trial Update: Recombinant Human Brain Natriuretic Peptide for the Recovery Stage of Septic Shock [NA]

View source ↗

Summary

This clinical trial is evaluating recombinant human brain natriuretic peptide for the recovery phase of septic shock in patients with sepsis-induced cardiomyopa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis
• Sepsis-induced Cardiomyopathy
• Septic Shock

Drugs mentioned

• Nesiritide (recombinant human B-type natriuretic peptide (rhBNP))

Snippet

Sponsor: Sichuan Provincial People's Hospital | Conditions: Sepsis-induced Cardiomyopathy, the Recovery Phase of Septic Shock | NA | Status: NOT_YET_RECRUITING